(GPCR)
0.00
0.00 (0.00%)

0.00
0.00 (0.00%)
| Tarkibi | |
|---|---|
| 3.08% | Insayderlar egalik qilgan aksiyalar ulushi |
| 95.85% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 98.89% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 270 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| FMR, LLC | 8.71M | 2025-12-31 | 12.30% | $400.07M |
| Wellington Management Group, LLP | 7.12M | 2025-12-31 | 10.05% | $327.04M |
| Avoro Capital Advisors LLC | 6.56M | 2025-12-31 | 9.25% | $301.03M |
| Janus Henderson Group PLC | 5.09M | 2025-12-31 | 7.19% | $233.74M |
| Deep Track Capital, Lp | 4.11M | 2025-12-31 | 5.80% | $188.81M |
| BVF Inc. | 3.48M | 2025-12-31 | 4.91% | $159.76M |
| Morgan Stanley | 2.09M | 2025-12-31 | 2.95% | $95.87M |
| Price (T.Rowe) Associates Inc | 1.67M | 2025-12-31 | 2.36% | $76.74M |
| Driehaus Capital Management, LLC | 1.64M | 2025-12-31 | 2.32% | $75.42M |
| Baker Bros. Advisors, LP | 1.43M | 2025-12-31 | 2.02% | $65.78M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.04M | 2025-10-31 | 4.29% | $139.40M |
| T. Rowe Price Health Sciences Fund, Inc. | 1.05M | 2025-12-31 | 1.49% | $48.37M |
| Fidelity Contrafund | 851,525 | 2026-01-31 | 1.20% | $39.10M |
| Fidelity Advisor Series I-Fidelity Advisor Growth Opportunities Fund | 816,000 | 2026-01-31 | 1.15% | $37.47M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 690,000 | 2026-01-31 | 0.97% | $31.68M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 632,638 | 2026-01-31 | 0.89% | $29.05M |
| Vanguard Explorer Fund | 582,447 | 2025-10-31 | 0.82% | $26.75M |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 574,288 | 2025-12-31 | 0.81% | $26.37M |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 504,589 | 2025-12-31 | 0.71% | $23.17M |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 499,717 | 2025-09-30 | 0.71% | $31.67M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 481,200 | 2026-01-31 | 0.68% | $22.10M |